Literature DB >> 16082285

Gamma-glutamyl transferase (GGT) as an independent predictive factor of sustained virologic response in patients with hepatitis C treated with interferon-alpha and ribavirin.

Cristiane Alves Villela-Nogueira1, Renata Mello Perez, Jorge André de Segadas Soares, Henrique Sérgio Moraes Coelho.   

Abstract

BACKGROUND: Recently, gamma-glutamyl transferase (GGT) has been investigated as a predictive factor for therapy response in hepatitis C patients, but so far its value in pretreatment screening has not been established. Therefore, this study aimed at evaluating GGT as an independent predictive factor for the response to treatment with interferon-alpha and ribavirin in hepatitis C virus (HCV)-infected patients.
METHODS: Naive chronic hepatitis C patients undergoing a 6-month follow-up after interferon-alpha and ribavirin therapy had their sustained virologic response (SVR) analyzed according to age, sex, body mass index, GGT levels, genotype, and liver histology by use of a multivariate logistic regression model.
RESULTS: Of the 211 patients studied with a mean age of 48+/-10 years, 125 (59%) were males. Overweight was detected in 47% of patients. Genotype 1 was detected in 141 (75%) of the 187 patients tested. Cirrhosis was present in 67 (32%). A high pretreatment GGT level was observed in 134 (63%). SVR was obtained in 84 (40%) patients. In the final logistic regression model, the variables independently associated with SVR were GGT (P<0.001), genotype (P<0.001), and liver histology (P<0.001).
CONCLUSION: A normal GGT level is an independent predictive factor for SVR in HCV-infected patients and should be considered for pretreatment screening.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082285     DOI: 10.1097/01.mcg.0000174025.19214.32

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

Review 1.  Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.

Authors:  Tzu-Hao Lee; Hans L Tillmann; Keyur Patel
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

Review 2.  Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Nathan Ford; Catherine Kirby; Kasha Singh; Edward J Mills; Graham Cooke; Adeeba Kamarulzaman; Philipp duCros
Journal:  Bull World Health Organ       Date:  2012-02-03       Impact factor: 9.408

3.  Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients.

Authors:  Rui Huang; Chen-Chen Yang; Yong Liu; Juan Xia; Ran Su; Ya-Li Xiong; Gui-Yang Wang; Zhen-Hua Sun; Xiao-Min Yan; Shan Lu; Chao Wu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

4.  Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.

Authors:  Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Naoki Hiramatsu; Fuminaka Sugauchi; Hiroshi Yatsuhashi; Namiki Izumi
Journal:  J Gastroenterol       Date:  2010-09-10       Impact factor: 7.527

5.  Gamma-Glutamyltransferase Activity (GGT) Is a Long-Sought Biomarker of Redox Status in Blood Circulation: A Retrospective Clinical Study of 44 Types of Human Diseases.

Authors:  Cui Bai; Meng Zhang; Yiran Zhang; Yixiong He; Huaiqian Dou; Ziyue Wang; Zhiliang Wang; Zipu Li; Lijuan Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-06-06       Impact factor: 7.310

6.  Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV).

Authors:  James E Everhart; Elizabeth C Wright
Journal:  Hepatology       Date:  2013-04-05       Impact factor: 17.425

7.  Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C.

Authors:  Dorota Orzechowska; Katarzyna Klimowicz; Anna Stępień; Tomasz Mikuła; Mariusz Sapuła; Alicja Wiercińska-Drapało
Journal:  Clin Exp Hepatol       Date:  2021-03-15

8.  The reduction of serum aminotransferase levels is proportional to the decline of the glomerular filtration rate in patients with chronic kidney disease.

Authors:  Luís Henrique Bezerra Cavalcanti Sette; Edmundo Pessoa de Almeida Lopes
Journal:  Clinics (Sao Paulo)       Date:  2015-05-01       Impact factor: 2.365

9.  A lower serum gamma-glutamyltransferase level does not predict a sustained virological response in patients with chronic hepatitis C genotype 1.

Authors:  Fatih Güzelbulut; Mesut Sezikli; Züleyha Akkan Cetinkaya; Selvinaz Ozkara; Can Gönen; Ayşe Oya Kurdaş Ovünç
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

10.  A low serum γ-glutamyltransferase level predicts a sustained virological response in patients with chronic hepatitis C genotype 1.

Authors:  Umit Bilge Dogan; Mustafa Salih Akin; Serkan Yalaki
Journal:  Gut Liver       Date:  2014-01-13       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.